实验室产品和服务外包市场规模、份额、趋势分析报告（按类型、技术、最终用途、地区、细分市场预测），2025 年至 2030 年

实验室产品和服务外包市场的成长和趋势：

根据Grand View Research, Inc.的最新报告，全球实验室产品和服务外包市场规模预计到2030年将达到671.2亿美元，2025年至2030年期间的复合年增长率为8.17%。

临床试验数量的增加、个人化医疗和新型治疗药物的采用日益增多、医疗保健行业研发投资的增加以及医疗设备的技术进步预计将对市场产生积极影响。

截至2023年5月17日，註册临床试验数量已达452,604项，其中64,838项正在积极招募市场参与企业。与2021年初报告的超过365,000项临床试验相比，这一显着增长标誌着临床研究领域的快速扩张。随着更多临床试验的启动，对支持研究各个方面（包括样本分析、检测和数据管理）的实验室产品和服务的需求也日益增长。这种日益增长的需求为外包公司创造了一个有利可图的机会，使其能够提供专业知识、先进技术和高效的解决方案，以满足临床试验不断变化的需求，从而推动市场成长。

医疗科技在市场中的整合是一个潜在的成长动力，正在拓宽医疗服务的格局。医疗技术涵盖广泛的设备、软体和服务，在改善诊断、治疗和疾病预防方面发挥关键作用。利用先进的医疗设备，例如影像系统（MRI、 电脑断层扫描）、治疗设备（心律调节器、人工关节）和诊断工具（血糖仪），外包公司可以提供专业知识和创新解决方案，以满足医疗产业不断变化的需求。此外，电子健康记录远端医疗平台等医疗软体和服务能够更有效率、更有效地提供医疗服务，进一步加速市场的成长轨迹。

个人化医疗和新型疗法的日益普及，尤其是基于人工智慧的个人化药物治疗和精准肿瘤学中的细胞治疗，凸显了更新法规结构的必要性。例如，到 2023 年 1 月，这些框架将确保创新方法安全有效地融入医疗保健系统。该论述强调了临床试验分散化的好处，以及透过在更贴近患者群体的地方进行临床试验来简化流程、降低成本和加强患者招募的潜力。此外，以患者为中心的原则已成为个人化医疗发展的基本方面，强调了在医疗决策中优先考虑患者的需求、偏好和价值观的重要性，尤其是在精准肿瘤学领域。然而，维护分散临床试验的品质和安全、管理个人化医疗的复杂性以及解决资料隐私和安全问题等挑战需要监管机构提出创新解决方案，以适应市场中不断变化的个人化医疗格局。

此外，医疗设备的技术进步是关键的成长动力，并将在未来几年产生重大影响。例如，利用 3D 列印技术为烧伤患者客製化植入、矫正器具和皮肤细胞，将增强个人化医疗设备的製造并改善患者的治疗效果。此外，使用 3D 列印开发人造器官可能会彻底改变器官移植并减少对捐赠器官的依赖。无氦移动 MRI 系统等创新将扩大患者获得诊断扫描的机会，同时解决环境问题。此外，人工智慧和巨量资料在医疗技术行业的整合，包括其在诊断和成像市场中的应用，有望带来变革性的好处，从而提高业务效率并推动实验室产品和服务外包领域的成长机会。

实验室产品和服务外包市场报告重点

• 根据产品类型，该产品细分市场将引领市场，占 2024 年全球收入份额的 62.38%。对先进和专用设备的高需求推动设备外包科学研究的进步导致了对准确和高效的实验室业务的需求，这导致对通用、分析、临床、支援和专用设备的需求增加。
• 从技术角度来看，分子诊断领域预计将在2024年占据主导地位，并在预测期内实现最快的复合年增长率。分子生物学技术的进步和个人化医疗方法的采用将进一步推动对分子诊断服务的需求。
• 根据最终用途，製药和生技公司将在预测期内（至 2024 年）占据主导地位。由于注重研发、外包趋势和对专业知识的需求，製药和生技公司正在推动实验室产品和服务外包的成长。
• 2024年，北美占据市场主导地位，市占率达38.99%。技术进步、严格的监管要求以及对专业服务日益增长的需求等因素促成了这一积极前景。此外，大型製药和生物技术公司的存在及其对研发的重视也有助于市场发展。

目录

第一章调查方法与范围

第二章执行摘要

第三章实验室产品和服务外包市场变数、趋势和范围

• 市场展望
  • 母市场展望
  • 补贴市场前景
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 定价模式分析
• 技术格局
• 经营模式分析
• 2024 年临床试验量分析
  • 各地区临床试验总数（2024年）
  • 各阶段临床试验总数（2024 年）
  • 依研究设计分类的临床试验总数（2024 年）
  • 按主要治疗领域分類的临床试验总数（2024 年）
• 实验室产品与服务外包市场：分析工具
  • 波特五力分析
  • PESTEL 与 SWOT 分析
  • COVID-19影响分析

第四章：实验室产品和服务外包市场：按类型估计和趋势分析

• 细分仪表板
• 全球实验室产品与服务外包市场波动分析
• 2018-2030 年全球实验室产品与服务外包市场规模及趋势分析（按类型）
• 产品
  • 装置
  • 一次性的
  • 其他的
• 服务
  • 製药
  • 其他的
  • 医疗设备

第五章：实验室产品与服务外包市场：技术评估与趋势分析

• 细分仪表板
• 全球实验室产品与服务外包市场波动分析
• 2018-2030 年全球实验室产品及服务外包市场规模及趋势分析（依技术）
• 免疫检测
• 分子诊断
• 微生物学
• 临床化学
• 流式细胞技术
• 质谱法
• 层析法
• 其他的

6. 实验室产品和服务外包市场：最终用途估计和趋势分析

• 细分仪表板
• 全球实验室产品与服务外包市场波动分析
• 2018 年至 2030 年全球实验室产品与服务外包市场规模及趋势分析（依最终用途）
• 製药和生物技术公司
• 医疗设备公司
• CRO 和 CDMO
• 其他的

第七章：实验室产品和服务外包市场：按类型、技术和最终用途进行的区域估计和趋势分析

• 区域市场仪表板
• 全球区域市场概况
• 2018年至2030年市场规模及预测趋势分析
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 丹麦
  • 瑞典
  • 挪威
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 泰国
• 拉丁美洲
  • 巴西
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 科威特

第八章 竞争态势

• 市场参与企业分类
• 服务热图分析（公司比较分析）
• 公司简介
  • Thermo Fisher Scientific
  • Charles River Laboratories
  • Eurofins Scientific
  • Labcorp
  • Quest Diagnostics
  • Parexel International Corporation
  • Agilent Technologies
  • PerkinElmer
  • Bio-Rad Laboratories
  • SGS SA
  • Intertek Group plc
  • WuXi AppTec Co., Ltd.

Laboratory Products & Services Outsourcing Market Growth & Trends:

The global laboratory products and services outsourcing market size is estimated to reach USD 67.12 billion by 2030, expanding at a CAGR of 8.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. A rising number of clinical trials, increased adoption of the personalized medicine and novel therapeutics, increasing R&D investment in the healthcare industry, technological advancement in the medical equipment are anticipated to positively influence the market.

The surge in registered clinical trials globally, reaching 452,604 as of May 17, 2023, with 64,838 actively recruiting participants, serves as a significant growth driver for the market. This notable increase from over 365,000 trials reported in early 2021 signifies a rapid expansion in the clinical research domain. As more trials are initiated, there is a heightened demand for laboratory products and services to support various aspects of research, including sample analysis, testing, and data management. This escalating need presents lucrative opportunities for outsourcing companies to provide specialized expertise, advanced technologies, and efficient solutions to meet the evolving requirements of clinical trials, thus driving the growth of the market.

The integration of medical technology within the market serves as a potential growth driver, enhancing the landscape of healthcare delivery. Medical technology, encompassing an extensive array of devices, software, and services, plays a pivotal role in improving diagnostics, treatment, and disease prevention. Leveraging advanced medical devices such as imaging systems (MRI, CT scans), therapeutic devices (pacemakers, artificial joints), and diagnostic tools (blood glucose meters), outsourcing companies can provide specialized expertise and innovative solutions to meet the evolving demands of the healthcare industry. Additionally, healthcare software and services, including electronic health records and telemedicine platforms, enable more efficient and effective care delivery, further fueling the growth trajectory of the market.

Increasing adoption of personalized medicine and novel therapeutics, particularly within AI-based personalized drug and cell therapies in precision oncology, highlights the necessity for updated regulatory frameworks. For instance, in January 2023, these frameworks ensure the safe and effective integration of innovative approaches into healthcare systems. Highlighting the benefits of decentralization in clinical trials, the discourse emphasizes its potential to streamline processes, reduce costs, and enhance patient recruitment by conducting trials closer to the patient population. Additionally, the principle of patient centricity emerges as a fundamental aspect of personalized medicine development, emphasizing the importance of prioritizing patients' needs, preferences, and values in healthcare decisions, particularly in precision oncology. However, challenges such as maintaining the quality and safety of decentralized trials, managing the complexities of personalized medicine, and addressing data privacy and security concerns require innovative solutions from regulatory bodies to adapt to the evolving landscape of personalized medicine within the market.

Furthermore, technological advancements in medical equipment present significant growth drivers, poised to make substantial impacts in the upcoming years. For instance, the utilization of 3D printing technology for custom implants, prosthetics, and skin cells for burn victims enhances the production of personalized medical devices, improving patient outcomes. Additionally, the development of artificial organs using 3D printing has the potential to revolutionize organ transplantation, reducing reliance on donor organs. Furthermore, innovations including mobile MRI systems with helium-free operations expand patient access to diagnostic scans while addressing environmental concerns. Moreover, integrating AI and Big Data in the medtech industry, including applications in diagnostics and imaging diagnostics markets, promises transformative benefits, enhancing operational efficiencies and driving growth opportunities in the laboratory products and services outsourcing sector.

Laboratory Products & Services Outsourcing Market Report Highlights:

• Based on type, the product segment led the market and accounted for 62.38% of global revenue share in 2024. High demand for sophisticated and specialized instruments drives equipment outsourcing. Advancements in scientific research necessitate precise and efficient laboratory operations, fueling the need for general, analytical, clinical, support, and specialty equipment.
• Based on technology, the molecular diagnostics segment dominated in 2024 and is expected to grow at the fastest CAGR during the forecast period. Advancements in molecular biology techniques and the adoption of personalized medicine approaches further boost the demand for molecular diagnostic services.
• Based on end-use, the pharmaceutical and biotech companies dominated in 2024. during the forecast period. Pharmaceutical & biotech companies drive growth in lab products and services outsourcing due to R&D focus, outsourcing trends, and demand for specialized expertise.
• North America dominated the market with a share of 38.99% in 2024. Factors such as technological advancements, stringent regulatory requirements, and the increasing demand for specialized services contribute to this positive outlook. Additionally, the presence of leading pharmaceutical and biotechnology companies and a strong emphasis on research and development further propels market expansion.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
  • 1.6.1. Region Wise Market: Base Estimates
  • 1.6.2. Global Market: CAGR Calculation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis (Model 1)
  • 1.7.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.7.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.7.4. Bottom-Up Approach (Model 4)
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Laboratory Products and Services Outsourcing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Pricing Model Analysis
• 3.4. Technology Landscape
• 3.5. Business Model Analysis
• 3.6. Clinical Trial Volume Analysis, 2024
  • 3.6.1. Total Number of Clinical Trials, by Region (2024)
  • 3.6.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.6.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.7. Laboratory Products And Services Outsourcing Market: Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL by SWOT Analysis
  • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Laboratory Products and Services Outsourcing Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
• 4.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Type, 2018 - 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.4.2. Equipment
    • 4.4.2.1. Equipment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.4.2.2. General
      • 4.4.2.2.1. General Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.4.2.3. Analytical
      • 4.4.2.3.1. Analytical Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.4.2.4. Clinical
      • 4.4.2.4.1. Clinical Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.4.2.5. Support
      • 4.4.2.5.1. Support Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.4.2.6. Specialty
      • 4.4.2.6.1. Specialty Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.4.3. Disposables
    • 4.4.3.1. Disposables Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.5.2. Pharmaceutical
    • 4.5.2.1. Pharmaceutical Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.5.2.2. Bioanalytical Testing
      • 4.5.2.2.1. Bioanalytical Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.2.2. ADME
        • 4.5.2.2.2.1. ADME Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.2.3. PK
        • 4.5.2.2.3.1. PK Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.2.4. PD
        • 4.5.2.2.4.1. PD Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.2.5. Bioavailability
        • 4.5.2.2.5.1. Bioavailability Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.2.6. Bioequivalence
        • 4.5.2.2.6.1. Bioequivalence Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.2.7. Others
        • 4.5.2.2.7.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.5.2.3. Method Development & Validation
      • 4.5.2.3.1. Method Development & Validation Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.3.2. Extractable & Leachable
        • 4.5.2.3.2.1. Extractable & Leachable Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.3.3. Impurity Method
        • 4.5.2.3.3.1. Impurity Method Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.3.4. Technical Consulting
        • 4.5.2.3.4.1. Technical Consulting Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.3.5. Others
        • 4.5.2.3.5.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.5.2.4. Stability Testing
      • 4.5.2.4.1. Stability Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.4.2. Drug Substance
        • 4.5.2.4.2.1. Drug substance Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.4.3. Stability Indicating Method Validation
        • 4.5.2.4.3.1. Stability Indicating Method Validation Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.4.4. Accelerated Stability Testing
        • 4.5.2.4.4.1. Accelerated Stability Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.4.5. Photostability Testing
        • 4.5.2.4.5.1. Photostability Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 4.5.2.4.6. Others
        • 4.5.2.4.6.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.5.3. Others
    • 4.5.3.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.5.4. Medical Device
    • 4.5.4.1. Medical Device Market Estimates and Forecast, 2018 -- 2030 (USD Million)
    • 4.5.4.2. Biocompatibility Tests
      • 4.5.4.2.1. Biocompatibility Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.5.4.3. Chemistry Test
      • 4.5.4.3.1. Chemistry Test Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.5.4.4. Microbiology & Sterility Testing
      • 4.5.4.4.1. Microbiology & Sterility Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.5.4.5. Others
      • 4.5.4.5.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 5. Laboratory Products and Services Outsourcing Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
• 5.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. Immunoassays
  • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.5. Molecular Diagnostics
  • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.6. Microbiology
  • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.7. Clinical Chemistry
  • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.8. Flow Cytometry
  • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.9. Mass Spectroscopy
  • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.10. Chromatography
  • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 5.11. Others
  • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Laboratory Products and Services Outsourcing Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
• 6.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotech Companies
  • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 6.5. Medical Device Companies
  • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 6.6. CRO & CDMO
  • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Laboratory Products and Services Outsourcing Market: Regional Estimates & Trend Analysis by Type, Technology & End Use

• 7.1. Regional Market Dashboard
• 7.2. Global Regional Market Snapshot
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Scenario
    • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Scenario
    • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.3. Japan
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Scenario
    • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Scenario
    • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Scenario
    • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Scenario
    • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Scenario
    • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Scenario
    • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Scenario
    • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Scenario
    • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Service Heat Map Analysis (a comparative analysis of the players together)
• 8.3. Company Profiles
  • 8.3.1. Thermo Fisher Scientific
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product/Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Charles River Laboratories
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product/Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Eurofins Scientific
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product/Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Labcorp
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product/Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Quest Diagnostics
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product/Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Parexel International Corporation
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product/Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Agilent Technologies
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product/Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. PerkinElmer
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product/Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Bio-Rad Laboratories
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product/Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. SGS SA
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product/Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Intertek Group plc
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Product/Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. WuXi AppTec Co., Ltd.
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Product/Service Benchmarking
    • 8.3.12.4. Strategic Initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 4 Global Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 5 Global Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 6 Global Laboratory Products and Services Outsourcing, by Region, 2018 - 2030 (USD Million)
• Table 7 North America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 9 North America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 10 North America Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 11 U.S. Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 12 U.S. Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 13 U.S. Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 15 Canada Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 16 Canada Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 17 Mexico Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 19 Mexico Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 20 Europe Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 21 Europe Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 22 Europe Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 23 Europe Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 24 Germany Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 25 Germany Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 26 Germany Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 27 UK Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 28 UK Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 29 UK Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 31 France Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 32 France Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 33 Italy Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 34 Italy Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 35 Italy Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 36 Spain Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 37 Spain Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 38 Spain Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 39 Denmark Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 40 Denmark Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 41 Denmark Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 42 Sweden Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 43 Sweden Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 44 Sweden Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 45 Norway Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 46 Norway Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 47 Norway Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 52 China Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 53 China Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 54 China Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 55 Japan Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 56 Japan Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 57 Japan Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 58 India Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 59 India Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 60 India Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 61 South Korea Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 62 South Korea Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 63 South Korea Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 64 Australia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 65 Australia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 66 Australia Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 67 Thailand Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 68 Thailand Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 69 Thailand Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 70 Latin America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 72 Latin America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 73 Latin America Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 74 Brazil Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 75 Brazil Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 76 Brazil Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 77 Argentina Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 78 Argentina Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 79 Argentina Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 84 South Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 85 South Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 86 South Africa Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 90 UAE Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 91 UAE Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 92 UAE Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
• Table 93 Kuwait Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
• Table 94 Kuwait Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
• Table 95 Kuwait Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Laboratory Products and Services Outsourcing, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 Global Laboratory Products and Services Outsourcing, for Product, 2018 - 2030 (USD Million)
• Fig. 13 Global Laboratory Products and Services Outsourcing, for Equipment, 2018 - 2030 (USD Million)
• Fig. 14 Global Laboratory Products and Services Outsourcing, for General, 2018 - 2030 (USD Million)
• Fig. 15 Global Laboratory Products and Services Outsourcing, for Analytical, 2018 - 2030 (USD Million)
• Fig. 16 Global Laboratory Products and Services Outsourcing, for Clinical, 2018 - 2030 (USD Million)
• Fig. 17 Global Laboratory Products and Services Outsourcing, for Support, 2018 - 2030 (USD Million)
• Fig. 18 Global Laboratory Products and Services Outsourcing, for Specialty, 2018 - 2030 (USD Million)
• Fig. 19 Global Laboratory Products and Services Outsourcing, for Disposables, 2018 - 2030 (USD Million)
• Fig. 20 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 21 Global Laboratory Products and Services Outsourcing, for Services, 2018 - 2030 (USD Million)
• Fig. 22 Global Laboratory Products and Services Outsourcing, for Pharmaceutical, 2018 - 2030 (USD Million)
• Fig. 23 Global Laboratory Products and Services Outsourcing, for Bioanalytical Testing, 2018 - 2030 (USD Million)
• Fig. 24 Global Laboratory Products and Services Outsourcing, for ADME, 2018 - 2030 (USD Million)
• Fig. 25 Global Laboratory Products and Services Outsourcing, for PK, 2018 - 2030 (USD Million)
• Fig. 26 Global Laboratory Products and Services Outsourcing, for PD, 2018 - 2030 (USD Million)
• Fig. 27 Global Laboratory Products and Services Outsourcing, for Bioavailability, 2018 - 2030 (USD Million)
• Fig. 28 Global Laboratory Products and Services Outsourcing, for Bioequivalence, 2018 - 2030 (USD Million)
• Fig. 29 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 30 Global Laboratory Products and Services Outsourcing, for Method Development and Validation, 2018 - 2030 (USD Million)
• Fig. 31 Global Laboratory Products and Services Outsourcing, for Extractable and Leachable, 2018 - 2030 (USD Million)
• Fig. 32 Global Laboratory Products and Services Outsourcing, for Impurity Method, 2018 - 2030 (USD Million)
• Fig. 33 Global Laboratory Products and Services Outsourcing, for Technical Consulting, 2018 - 2030 (USD Million)
• Fig. 34 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 35 Global Laboratory Products and Services Outsourcing, for Stability Testing, 2018 - 2030 (USD Million)
• Fig. 36 Global Laboratory Products and Services Outsourcing, for Drug Substance, 2018 - 2030 (USD Million)
• Fig. 37 Global Laboratory Products and Services Outsourcing, for Stability Indicating Method Validation, 2018 - 2030 (USD Million)
• Fig. 38 Global Laboratory Products and Services Outsourcing, for Accelerated Stability Testing, 2018 - 2030 (USD Million)
• Fig. 39 Global Laboratory Products and Services Outsourcing, for Photostability Testing, 2018 - 2030 (USD Million)
• Fig. 40 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 41 Global Laboratory Products and Services Outsourcing, for Medical Device, 2018 - 2030 (USD Million)
• Fig. 42 Global Laboratory Products and Services Outsourcing, for Biocompatibility Tests, 2018 - 2030 (USD Million)
• Fig. 43 Global Laboratory Products and Services Outsourcing, for Chemistry Test, 2018 - 2030 (USD Million)
• Fig. 44 Global Laboratory Products and Services Outsourcing, for Microbiology & Sterility Testing, 2018 - 2030 (USD Million)
• Fig. 45 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 46 Global Laboratory Products and Services Outsourcing, for Immunoassays, 2018 - 2030 (USD Million)
• Fig. 47 Global Laboratory Products and Services Outsourcing, for Molecular Diagnostics, 2018 - 2030 (USD Million)
• Fig. 48 Global Laboratory Products and Services Outsourcing, for Microbiology, 2018 - 2030 (USD Million)
• Fig. 49 Global Laboratory Products and Services Outsourcing, for Clinical Chemistry, 2018 - 2030 (USD Million)
• Fig. 50 Global Laboratory Products and Services Outsourcing, for Flow Cytometry, 2018 - 2030 (USD Million)
• Fig. 51 Global Laboratory Products and Services Outsourcing, for Chromatography, 2018 - 2030 (USD Million)
• Fig. 52 Global Laboratory Products and Services Outsourcing, for Mass Spectroscopy, 2018 - 2030 (USD Million)
• Fig. 53 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 54 Global Laboratory Products and Services Outsourcing, for Medical Device Companies, 2018 - 2030 (USD Million)
• Fig. 55 Global Laboratory Products and Services Outsourcing, for Pharmaceutical & Biotech Companies, 2018 - 2030 (USD Million)
• Fig. 56 Global Laboratory Products and Services Outsourcing, for CRO & CDMO, 2018 - 2030 (USD Million)
• Fig. 57 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
• Fig. 58 Regional Outlook, 2024 & 2030
• Fig. 59 North America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 U.S. Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Canada Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Mexico Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Europe Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Germany Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 UK Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 France Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Italy Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Spain Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Denmark Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Sweden Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Norway Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Asia Pacific Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Japan Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 74 China Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 75 India Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Australia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 77 South Korea Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Thailand Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Latin America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Brazil Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Argentina Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Middle East and Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 83 South Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Saudi Arabia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 85 UAE Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Kuwait Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)